Cargando…

398 Researcher Perceived Barriers in Translational Research

OBJECTIVES/GOALS: To identify, categorize, and streamline the wide range of commonly encountered barriers in translational research that prevent studies from progressing along the translational research spectrum through a comprehensive needs assessment survey. Results will be utilized to institute p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mukherjee, Sunaina, Gonzalez, Anthony, Anwar, Farah, Parzecki, Isabel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2023
Materias:	Regulatory Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129457/ http://dx.doi.org/10.1017/cts.2023.433

Ejemplares similares

392 Basic Researcher Interviews to iDentify Gaps to Enabling Translation (BRIDGE Translation)
por: Thepmankorn, Parisorn, et al.
Publicado: (2023)

Drug Lag and Key Regulatory Barriers in the Emerging Markets
por: Wileman, Harriet, et al.
Publicado: (2010)

Translating New Science Into the Drug Review Process: The US FDA’s Division of Applied Regulatory Science
por: Rouse, Rodney, et al.
Publicado: (2017)

Regulations and guidelines governing stem cell based products: Clinical considerations
por: George, Bobby
Publicado: (2011)

Regulatory Considerations for Biosimilars
por: Nellore, Ranjani
Publicado: (2010)

Registration of Medical Devices
por: George, Bobby
Publicado: (2010)

Implications of ICH-E5: Assessment of drug's sensitivity to ethnic factors and necessity of a bridging study for global drug development
por: Gupta, Sandeep Kumar
Publicado: (2011)

Regulatory requirements for marketing fixed dose combinations
por: Jayasheel, B. G.
Publicado: (2010)

Injury and death in clinical trials and compensation: Rule 122 DAB
por: Ghooi, Ravindra. B.
Publicado: (2013)

Key points of technical review for the registration of SARS-CoV-2 antigen/antibody tests
por: Li, Hongran, et al.
Publicado: (2021)

China NMPA perspective on clinical evaluation of SARS-CoV-2 antibody test reagents in the process of emergency approval
por: Lv, Yunfeng, et al.
Publicado: (2020)

Key points of technical review for the registration of SARS-CoV-2 nucleic acid tests in China
por: Li, Hongran, et al.
Publicado: (2021)

China's NMPA perspective on the clinical performance of SARS-CoV-2 antigen test reagents
por: Lv, Yunfeng, et al.
Publicado: (2022)

Conducting a phase III clinical trial in children during the COVID- 19 pandemic: Experience and lessons learnt from a clinical research facility of Nepal
por: Chapagain, Ram Hari, et al.
Publicado: (2023)

399 The development of a digital game to prevent suicide in youth who misuse substances
por: Fernandes, Claudia-Santi F., et al.
Publicado: (2023)

397 Regulations and Marketing of Energy Drinks in the United States: A Survey of University Student Beliefs about Caffeine Consumption
por: Chung, Christian, et al.
Publicado: (2023)

391 An Investigation on the Activity of Repurposing Already Marketed Drugs for New Indications from 2015 to 2021.
por: Wu, Wenchao, et al.
Publicado: (2023)

395 Hindering Generic Antiretroviral Treatment Competition for Human Immunodeficiency Virus: Anti-Competitive Agreements and HIV Disease Management Concerns
por: Crovetto, Arianna
Publicado: (2023)

394 Examining the Landscape of Clinical Trials Targeting Alcohol or Opioid Use Among Homeless Individuals
por: Baltazar, Bruno, et al.
Publicado: (2023)

393 Disposable Electronic Nicotine Delivery Systems (ENDS) and Underage Nicotine Addiction–A Survey of College Students
por: Riggs, Griffin, et al.
Publicado: (2023)

390 A Mixed Methods Review of Endpoint Measures Utilized in Adult ADHD Medication Clinical Trial Design
por: Davies, Claire, et al.
Publicado: (2023)

396 Quantitative Analysis of FDA Warning Letters Related to the Use of Social Media Sites in Product Misbranding for the Treatment, Prevention, or Diagnosis of COVID-19
por: Ajaj, Mahmoud, et al.
Publicado: (2023)

400 Exploring the Diversity of Expanded Access Patients at Michigan Medicine
por: Gravelin, Misty, et al.
Publicado: (2023)

Good Clinical Practice Training: Identifying Key Elements and Strategies for Increasing Training Efficiency
por: Arango, Jaime, et al.
Publicado: (2016)

Advancing a Framework for Regulatory Use of Real-World Evidence: When Real Is Reliable
por: Dreyer, Nancy A.
Publicado: (2018)

Survey of Japanese Orphan Drug Program: Factors Related to Successful Marketing Approval
por: Harada, Kenji, et al.
Publicado: (2019)

4505 Implementation of Real-World Data and Real-World Evidence in Clinical Studies
por: Pham, Jessica, et al.
Publicado: (2020)

4186 Single IRB and the CTSI: Liaison Model for the IRB Reliance Process
por: Caldwell, Christine Sego, et al.
Publicado: (2020)

4349 Survey of Regulatory Reforms to Address Comprehension of Clinical Trial Results
por: Kirkland, Matthieu, et al.
Publicado: (2020)

4500 Providing a System for Practical Monitoring Training for Clinical Trials within Academic Institutions
por: Chandramohan, Advaita, et al.
Publicado: (2020)

81007 Training Biomedical Engineers in Regulatory Science: Critical Role of Experts from Industry and FDA
por: Lottes, Aaron E., et al.
Publicado: (2021)

95347 Examining the Impact of the BPCA: Promoting Pediatric Inclusion in Clinical Trials and Pediatric-Specific Drug Information
por: Ly, Annie, et al.
Publicado: (2021)

Investigating the effects of differently produced synthetic amorphous silica (E 551) on the integrity and functionality of the human intestinal barrier using an advanced in vitro co-culture model
por: Hempt, Claudia, et al.
Publicado: (2020)

3523 Innovative Approaches to Clinical Research on Placebo Effects: A Regulatory Science Perspective
por: Uweh, Kimberly
Publicado: (2019)

2389: I-Corps at NCATS: Toward entrepreneurial training for clinical and translational investigators and lessons learned in team-based customer and stakeholder discovery
por: Wasko, Molly, et al.
Publicado: (2018)

Species differences and human relevance of the toxicity of 4-hydroxyphenylpyruvate dioxygenase (HPPD) inhibitors and a new approach method in vitro for investigation
por: Botham, Jane, et al.
Publicado: (2023)

A mixture of 13 pesticides, contaminants, and food additives below individual NOAELs produces histopathological and organ weight changes in rats
por: Dinca, Viorica, et al.
Publicado: (2023)

Modernizing persistence–bioaccumulation–toxicity (PBT) assessment with high throughput animal-free methods
por: Escher, Beate I., et al.
Publicado: (2023)

Next generation risk assessment of human exposure to estrogens using safe comparator compound values based on in vitro bioactivity assays
por: van Tongeren, Tessa C. A., et al.
Publicado: (2023)

The EMA Assessment of Asciminib for the Treatment of Adult Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase Who Were Previously Treated With at Least Two Tyrosine Kinase Inhibitors
por: Tesileanu, C Mircea S, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d7hskrta389bo80nimv4u3sbrj